Cargando…
Directed Differentiation of Human Induced Pluripotent Stem Cells into Dendritic Cells Displaying Tolerogenic Properties and Resembling the CD141(+) Subset
The advent of induced pluripotent stem cells (iPSCs) has begun to revolutionize cell therapy by providing a convenient source of rare cell types not normally available from patients in sufficient numbers for therapeutic purposes. In particular, the development of protocols for the differentiation of...
Autores principales: | Sachamitr, Patty, Leishman, Alison J., Davies, Timothy J., Fairchild, Paul J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5766641/ https://www.ncbi.nlm.nih.gov/pubmed/29358940 http://dx.doi.org/10.3389/fimmu.2017.01935 |
Ejemplares similares
-
Induced pluripotent stem cells reprogrammed from primary dendritic cells provide an abundant source of immunostimulatory dendritic cells for use in immunotherapy
por: Horton, Christopher, et al.
Publicado: (2019) -
Induced Pluripotent Stem Cells: Challenges and Opportunities for Cancer Immunotherapy
por: Sachamitr, Patty, et al.
Publicado: (2014) -
Rapamycin Conditioning of Dendritic Cells Differentiated from Human ES Cells Promotes a Tolerogenic Phenotype
por: Silk, Kathryn M., et al.
Publicado: (2012) -
Role of the Immunogenic and Tolerogenic Subsets of Dendritic Cells in Multiple Sclerosis
por: Xie, Zhong-Xiang, et al.
Publicado: (2015) -
Differential Gene Expression in Thrombomodulin (TM; CD141)(+) and TM(−) Dendritic Cell Subsets
por: Toda, Masaaki, et al.
Publicado: (2013)